Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/17/23 16:42 | 11/17/23 | XTNT | Health | BioPrd | Biological Products, (No Diag | Brandt Kevin D | MT | O | Chief Co | P | 50 | 1.20 | 0 | 42 | 5 | 816 | D | ||||||||||||||
1/19/23 16:23 | 1/18/23 | XTNT | Health | BioPrd | Biological Products, (No Diag | Neils Scott C | MT | O | CFO | S | -5 | 0.6091 | 0 | -9 | -2 | 404 | D | ||||||||||||||
10/20/22 16:19 | 10/18/22 | XTNT | Health | BioPrd | Biological Products, (No Diag | Browne Sean E | MT | DO | P,CEO | S.m | -86 | 0.6547 | 0 | -131 | -8 | 1,507 | D | ||||||||||||||
10/11/22 16:48 | 10/7/22 | XTNT | Health | BioPrd | Biological Products, (No Diag | Vizirgianakis Stavros G. | MT | D | P.d | 1,087 | 0.4800 | 0 | 2,265 | 63 | 5,851 | D | |||||||||||||||
8/17/22 17:28 | 8/16/22 | XTNT | Health | BioPrd | Biological Products, (No Diag | Brandt Kevin D | MT | O | Chief Co | S.m | -11 | 0.4879 | 0 | -23 | -3 | 704 | D | ||||||||||||||
8/17/22 17:10 | 8/16/22 | XTNT | Health | BioPrd | Biological Products, (No Diag | Neils Scott C | MT | O | CFO | S.m | -3 | 0.4812 | 0 | -6 | -2 | 413 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |